Baltimore firm raises $110 million to bring Johns Hopkins' cancer-detecting blood test to market
from The Baltimore Sun
A newly formed Baltimore company has raised $110 million to develop and commercialize a cancer-detecting blood test, created by Johns Hopkins researchers, that doctors would give patients during routine physicals.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063